Page last updated: 2024-08-26

2,3-bis(4-hydroxyphenyl)-propionitrile and Bladder Cancer

2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Bladder Cancer in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Hata, S; Ise, K; Ito, A; Nakamura, Y; Sasano, H; Sato, N; Yamashita, S1
Downes, M; Gudas, LJ; Kauffman, EC; Marcinkiewicz, K; Mongan, NP; Robinson, BD; Scherr, DS; Vourganti, S1
Cui, D; Han, B; Hong, Y; Jing, Y; Xia, S1
Bjorling, DE; Jarrard, DF; Teng, J; Wang, ZY1

Other Studies

4 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Bladder Cancer

ArticleYear
Clinicopathological Significance of Estrogen Receptor
    Pathology oncology research : POR, 2021, Volume: 27

    Topics: Aromatase; Biomarkers, Tumor; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Proliferation; Estradiol; Estrogen Receptor beta; Estrogens; Female; Humans; Nitriles; Propionates; Steryl-Sulfatase; Sulfotransferases; Urinary Bladder Neoplasms

2021
Estrogen receptor-β expression and pharmacological targeting in bladder cancer.
    Oncology reports, 2013, Volume: 30, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Proliferation; Cystectomy; Disease-Free Survival; Estrogen Receptor beta; Estrogens; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Propionates; Signal Transduction; Survival; Tamoxifen; Urinary Bladder Neoplasms; Urothelium

2013
Estrogen receptor β (ERβ) is a novel prognostic marker of recurrence survival in non-muscle-invasive bladder cancer potentially by inhibiting cadherin switch.
    World journal of urology, 2012, Volume: 30, Issue:6

    Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Cadherins; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Movement; Estrogen Receptor beta; Female; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Male; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Prognosis; Propionates; Retrospective Studies; Survival Rate; Urinary Bladder Neoplasms; Urothelium

2012
Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation.
    Endocrine-related cancer, 2008, Volume: 15, Issue:1

    Topics: Blotting, Western; Carcinoma, Transitional Cell; Cell Proliferation; Cyclin D; Cyclin E; Cyclins; DNA Primers; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Flow Cytometry; G1 Phase; Humans; Immunoenzyme Techniques; Ligands; MAP Kinase Kinase Kinases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitriles; Phenols; Pyrazoles; Response Elements; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; S Phase; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Urothelium

2008